Financials

News Discussions Technicals Seasonals

FAB fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Fusion Antibodies Plc engages in research, development, and manufacturing recombinant proteins and antibodies, particularly in the areas of cancer and infectious diseases. The firm also offers antibody engineering services for all stages of therapeutic and diagnostic antibody development. The company was founded by Michael Townsley and James Anthony Johnston on November 29, 2000 and is headquartered in Dunmurry, the United Kingdom.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

FAB has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company